Our mission is to cut through the noise with solutions to see the information you really want—bringing an end to wasted sequencing reads and uninformative data.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $21M
Founded date: 2016
Investors 1
| Date | Name | Website |
| 17.07.2021 | Baird Capi... | bairdcapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.01.2021 | Series B | $21M | - |
Mentions in press and media 3
| Date | Title | Description |
| 19.02.2021 | Jumpcode Genomics Raises $21M in Series B Funding | Jumpcode Genomics, a San Diego, CA-based genome technology company focused on improving the understanding of human disease, raised $21m in Series B funding. The round, announced in January 2021, was co-led by Baird Capital and Arboretum Ven... |
| 20.01.2021 | Jumpcode Secures $21M | Jumpcode Genomics, a genome technology company focused on improving the understanding of human disease, has raised $21 million in a Series B round of funding. The round was co-led by Baird Capital and Arboretum Ventures and included existin... |
| 12.01.2021 | Baird Capital Invests in Jumpcode Genomics | Baird Capital announced today that its venture team has completed an investment in Jumpcode Genomics ("Jumpcode"), a genome technology company focused on improving the understanding of human disease. Joining Baird Capital in the $... |